Raymond James Financial Inc. bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 492,046 shares of the company's stock, valued at approximately $6,613,000. Raymond James Financial Inc. owned approximately 0.20% of Oscar Health as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its position in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after buying an additional 8,051,379 shares during the last quarter. BIT Capital GmbH lifted its holdings in Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after purchasing an additional 4,396,872 shares during the last quarter. Hennessy Advisors Inc. increased its holdings in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the last quarter. Clearbridge Investments LLC acquired a new position in shares of Oscar Health in the fourth quarter valued at $19,088,000. Finally, American Century Companies Inc. raised its position in shares of Oscar Health by 185.6% in the fourth quarter. American Century Companies Inc. now owns 1,285,204 shares of the company's stock valued at $17,273,000 after purchasing an additional 835,144 shares during the period. 75.70% of the stock is owned by institutional investors.
Oscar Health Stock Performance
Shares of Oscar Health stock traded up $0.39 during trading hours on Tuesday, reaching $13.01. The company had a trading volume of 1,340,663 shares, compared to its average volume of 3,884,695. The business has a fifty day simple moving average of $13.49 and a 200 day simple moving average of $14.76. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market cap of $3.26 billion, a PE ratio of -646.93 and a beta of 1.75. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Analyst Ratings Changes
Separately, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $20.21.
Check Out Our Latest Analysis on OSCR
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.